Enanta Pharmaceuticals
ENTA
#8088
Rank
ยฃ0.28 B
Marketcap
ยฃ9.72
Share price
-2.08%
Change (1 day)
70.26%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -ยฃ38.14 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ69.21 Million. In 2025 the company made an earning of -ยฃ47.25 Million, an increase over its 2024 earnings that were of -ยฃ71.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ38.14 Million-19.28%
2025 -ยฃ47.25 Million-34.07%
2024 -ยฃ71.67 Million-23.87%
2023 -ยฃ94.14 Million4.39%
2022 -ยฃ90.18 Million-4.4%
2021 -ยฃ94.33 Million91.12%
2020 -ยฃ49.36 Million-407.13%
2019 ยฃ16.07 M-78.63%
2018 ยฃ75.21 M117.97%
2017 ยฃ34.5 M-574.65%
2016 -ยฃ7.27 Million-110.83%
2015 ยฃ67.14 M-4.5%
2014 ยฃ70.3 M-638.53%
2013 -ยฃ13.06 Million-137.98%
2012 ยฃ34.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.19 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.66 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.41 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.73 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.71 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.09 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA